Literature DB >> 3821100

Differential distribution of the 5-alpha-reductase in the central nervous system of the rat and the mouse: are the white matter structures of the brain target tissue for testosterone action?

F Celotti, R C Melcangi, P Negri-Cesi, M Ballabio, L Martini.   

Abstract

In the brain of several animal species testosterone is converted into a series of 5-alpha-reduced metabolites, and especially into 17-beta-hydroxy-5-alpha-androstan-3-one (DHT), by the action of the enzyme 5-alpha-reductase. The formation of DHT has never been evaluated in the white matter structures of the brain, which are composed mainly of myelinated axons. The experiments here described were performed in order to study, in the rat and the mouse, the DHT forming activity of several white matter structures, in comparison with that of the cerebral cortex and of the hypothalamus. Two sampling techniques were used in the rat: microdissection under a stereo-microscope from frozen brain sections of fragments of corpus callosum, optic chiasm and cerebral cortex; fresh tissue macrodissection of subcortical white matter, cerebral cortex and hypothalamus. Only macrodissection was used in the mice. The data show that, independently from the sampling technique used, there are considerable quantitative differences in the distribution pattern of the 5-alpha-reductase activity within different brain structures. Both in the rat and in the mouse, the enzyme appears to be present in higher concentrations in the white matter structures, than in the cerebral cortex and in the hypothalamus. The present results clearly show that the subcortical white matter and the corpus callosum are at least three times as potent as the cerebral cortex in converting testosterone into DHT. An even higher 5-alpha-reductase activity has been found in the optic chiasm. Further work is needed in order to understand the possible physiological role of DHT formation in the white matter structures.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3821100     DOI: 10.1016/0022-4731(87)90040-9

Source DB:  PubMed          Journal:  J Steroid Biochem        ISSN: 0022-4731            Impact factor:   4.292


  8 in total

1.  Expression in Escherichia Coli, Purification, and Functional Reconstitution of Human Steroid 5α-Reductases.

Authors:  Hwei-Ming Peng; Juan Valentín-Goyco; Sang-Choul Im; Bing Han; Jiayan Liu; Jie Qiao; Richard J Auchus
Journal:  Endocrinology       Date:  2020-08-01       Impact factor: 4.736

2.  Quantifying mRNA levels across tissue sections with 2D-RT-qPCR.

Authors:  Michael Armani; Michael A Tangrea; Benjamin Shapiro; Michael R Emmert-Buck; Elisabeth Smela
Journal:  Anal Bioanal Chem       Date:  2011-05-11       Impact factor: 4.142

3.  Metabolism of 27-, 25- and 24-hydroxycholesterol in rat glial cells and neurons.

Authors:  J Zhang; Y Akwa; M el-Etr; E E Baulieu; J Sjövall
Journal:  Biochem J       Date:  1997-02-15       Impact factor: 3.857

Review 4.  Effects of adrenal cortex hormones on limbic structures: some experimental and clinical correlations related to depression.

Authors:  B Dubrovsky
Journal:  J Psychiatry Neurosci       Date:  1993-01       Impact factor: 6.186

5.  Effects of adrenocortical steroids on long-term potentiation in the limbic system: basic mechanisms and behavioral consequences.

Authors:  B Dubrovsky; K Gijsbers; D Filipini; M K Birmingham
Journal:  Cell Mol Neurobiol       Date:  1993-08       Impact factor: 5.046

Review 6.  Reflections on the diseases linked to mutations of the androgen receptor.

Authors:  Angelo Poletti; Paola Negri-Cesi; Luciano Martini
Journal:  Endocrine       Date:  2005-12       Impact factor: 3.925

7.  Sex-dependent changes in neuroactive steroid concentrations in the rat brain following acute swim stress.

Authors:  Ying Sze; Andrew C Gill; Paula J Brunton
Journal:  J Neuroendocrinol       Date:  2018-10-07       Impact factor: 3.627

8.  Ontogeny and autoregulation of androgen receptor mRNA expression in the nervous system.

Authors:  W J Young; C Chang
Journal:  Endocrine       Date:  1998-08       Impact factor: 3.925

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.